510(k) K181334

ADVIA Centaur Herpes-2 IgG by Biokit, S.A. — Product Code MYF

K181334 is an FDA 510(k) premarket notification submitted by Biokit, S.A. for the device "ADVIA Centaur Herpes-2 IgG". The FDA issued a decision of Substantially Equivalent on August 23, 2018. The device falls under product code MYF (Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-2), a Class II device regulated under 21 CFR 866.3305. Biokit, S.A. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
August 23, 2018
Date Received
May 21, 2018
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-2
Device Class
Class II
Regulation Number
866.3305
Review Panel
MI
Submission Type